fromNature2 weeks agoCoronavirusA front-line antiviral drug disappoints against worrisome monkeypox strainTecovirimat, approved in Europe for mpox, showed limited effectiveness in hastening recovery in human clinical trials.
Coronavirusfromwww.nytimes.com4 months agoPaxlovid Improved Long Covid Symptoms in Some Patients, Researchers ReportPaxlovid may benefit some long Covid patients, but results vary significantly and the underlying causes remain unclear.